• Science & Technology

Personalised blood test could help predict which lung cancers might return

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

1 April 2022

• Health & Medicine

Is there a right way to check your body for cancer? 

There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking. There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking.

29 March 2022

• Science & Technology

Piecing together the puzzle: Antibiotics, the microbiome and bowel cancer

Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play. Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play.

15 March 2022

• Science & Technology

Paving the way: How biopsies are offering hope to children with aggressive brain tumours

7 March 2022

• Health & Medicine

Reduction in women screened for breast cancer between 2020 and 2021, NHS report finds

A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic. A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.

25 February 2022

• Health & Medicine

No link between breast pain alone and cancer diagnosis, study finds

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms. Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

22 February 2022

• Science & Technology

Advanced MRI could help to differentiate aggressive and slower growing prostate cancer

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways. New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.

14 February 2022

• Science & Technology
• For Researchers

Disease in a dish: Mini-gut organoids and the challenges of bowel cancer

Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments. Disrupted cell signalling, hijacked stem cells and the power of 'mini-guts' – we hear from Dr Vivian Li on the challenges and opportunities of developing colorectal cancer treatments.

11 February 2022

• Health & Medicine

Aromatase inhibitors cut breast cancer recurrence in younger patients

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

11 February 2022

• Health & Medicine

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England. Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

28 January 2022

• Health & Medicine

New breast and lung cancer treatments approved in Scotland

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer. 3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

19 January 2022

• Health & Medicine

New lung cancer treatment combo approved on NHS in England

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE). A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

12 January 2022